Summary
Elevance Health, Inc. (formerly WellPoint, Inc.) reported total revenues of $15.14 billion for the first quarter of 2009, a slight decrease of 3% from the same period in 2008, primarily due to lower premium revenues and net investment income. Net income was $580.4 million, a 1% decrease year-over-year, resulting in diluted EPS of $1.16, an increase of 8% driven by a reduced share count from buybacks. The company experienced a notable increase in net realized losses on investments, largely attributable to other-than-temporary impairments on equity and fixed maturity securities, impacting profitability. Operating cash flow showed strength, increasing by 14% to $1.19 billion, indicating solid cash generation from core operations.
Financial Highlights
29 data pointsBeta
Financial Statements
Beta
Key Highlights
- 1Total operating revenue for Q1 2009 was $15.3 billion, a slight decrease of less than 1% compared to Q1 2008.
- 2Net income for Q1 2009 was $580.4 million, a decrease of 1% from Q1 2008.
- 3Diluted earnings per share (EPS) increased by 8% to $1.16 in Q1 2009, primarily due to a lower number of outstanding shares from share repurchases.
- 4Net realized losses on investments significantly increased to $352.5 million in Q1 2009, primarily due to other-than-temporary impairments on securities.
- 5Operating cash flow strengthened by 14% to $1.19 billion in Q1 2009.
- 6The company announced an agreement to sell its PBM operations (NextRx) to Express Scripts for $4.675 billion in April 2009.
- 7Medical membership saw a decrease of 2% year-over-year, totaling 34.6 million members as of March 31, 2009.
Frequently Asked Questions
For the first quarter of 2009, Elevance Health (WellPoint) reported total revenues of $15.14 billion, a slight decrease of 3% compared to the prior year. Net income was $580.4 million, down 1% year-over-year. Diluted EPS rose 8% to $1.16, largely due to share buybacks reducing the share count. Operating cash flow increased significantly by 14% to $1.19 billion.
A major announcement was the definitive agreement to sell its pharmacy benefit management (PBM) operations, NextRx, to Express Scripts for $4.675 billion, announced in April 2009. The company also completed the acquisition of DeCare Dental, LLC, in April 2009. Additionally, in February 2009, the company issued $1 billion in long-term debt.
Investment performance had a negative impact, with net realized losses on investments soaring to $352.5 million in Q1 2009, a substantial increase from $45.6 million in Q1 2008. This was primarily driven by significant other-than-temporary impairments on both equity securities ($169.7 million) and fixed maturity securities ($135.3 million), reflecting challenging market conditions.
Total medical membership decreased by 2% year-over-year to 34.6 million members as of March 31, 2009. This decline was primarily attributed to decreases in Local Group, State-Sponsored, and Individual businesses. Self-funded membership saw a slight increase, while fully-insured membership decreased. Ancillary businesses like Dental also experienced declines, while Vision and Behavioral Health saw increases.